HOLLY GUTTSHALL: Open Payments
NPI 1437697893 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,623 in 120 payments from 19 companies in 2025. Trend: 2023 $2,010 · 2024 $2,477 · 2025 $2,623
Food & beverage: $2,472Education: $151
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $474 |
| PFIZER INC. | 10 | $270 |
| ABBVIE INC. | 27 | $262 |
| Janssen Biotech, Inc. | 9 | $235 |
| Galderma Laboratories, L.P. | 12 | $223 |
| GENZYME CORPORATION | 9 | $193 |
| Novartis Pharmaceuticals Corporation | 6 | $185 |
| UCB, Inc. | 3 | $173 |
| LEO Pharma Inc. | 5 | $137 |
| REVANCE THERAPEUTICS, INC. | 2 | $104 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, CIBINQO, RINVOQ, LITFULO, SKYRIZI.
Industry payments across GA — which companies pay providers there.
